PDF(Pubmed)
Abstract：
BACKGROUND: To retrospectively report the safety and efficacy of renal transcatheter arterial embolization for treating autosomal dominant polycystic kidney disease (ADPKD) patients with gross hematuria.
METHODS: The purpose of this study is to retrospectively report the safety and efficacy of renal transcatheter arterial embolization for treating ADPKD patients with gross hematuria. Materials and methods: During the period from January 2018 to December 2019, renal transcatheter arterial embolization was carried out on 6 patients with polycystic kidneys and gross hematuria. Renal arteriography was performed first, and then we determined the location of the hemorrhage and performed embolization under digital subtraction angiography monitoring. Improvements in routine blood test results, routine urine test results, urine color and postoperative reactions were observed and analyzed. Results: Renal transcatheter arterial embolization was successfully conducted in 6 patients. The indices of 5 patients and the color of gross hematuria improved after surgery compared with before surgery. No severe complication reactions occurred.
CONCLUSIONS: For autosomal dominant polycystic kidney syndrome patients with gross hematuria, transcatheter arterial embolization was safe and effective.
METHODS: The purpose of this study is to retrospectively report the safety and efficacy of renal transcatheter arterial embolization for treating ADPKD patients with gross hematuria. Materials and methods: During the period from January 2018 to December 2019, renal transcatheter arterial embolization was carried out on 6 patients with polycystic kidneys and gross hematuria. Renal arteriography was performed first, and then we determined the location of the hemorrhage and performed embolization under digital subtraction angiography monitoring. Improvements in routine blood test results, routine urine test results, urine color and postoperative reactions were observed and analyzed. Results: Renal transcatheter arterial embolization was successfully conducted in 6 patients. The indices of 5 patients and the color of gross hematuria improved after surgery compared with before surgery. No severe complication reactions occurred.
CONCLUSIONS: For autosomal dominant polycystic kidney syndrome patients with gross hematuria, transcatheter arterial embolization was safe and effective.
摘要：
背景：回顾性报道经肾动脉栓塞治疗常染色体显性遗传性多囊肾病（ADPKD）伴肉眼血尿患者的安全性和有效性。
方法：本研究的目的是回顾性报道经肾动脉栓塞治疗ADPKD伴肉眼血尿患者的安全性和有效性。材料与方法:2018年1月至2019年12月期间,对6例多囊肾伴肉眼血尿患者行肾经导管动脉栓塞术。首先进行肾动脉造影,然后我们确定出血的位置并在数字减影血管造影监测下进行栓塞。血常规检查结果的改善,尿常规检查结果,观察并分析尿液颜色和术后反应。结果:6例患者均成功行肾动脉栓塞术。5例患者术后各项指标及肉眼血尿颜色较术前改善。无严重并发症反应发生。
结论：对于常染色体显性多囊肾综合征伴肉眼血尿患者，经导管动脉栓塞术是安全有效的。
方法：本研究的目的是回顾性报道经肾动脉栓塞治疗ADPKD伴肉眼血尿患者的安全性和有效性。材料与方法:2018年1月至2019年12月期间,对6例多囊肾伴肉眼血尿患者行肾经导管动脉栓塞术。首先进行肾动脉造影,然后我们确定出血的位置并在数字减影血管造影监测下进行栓塞。血常规检查结果的改善,尿常规检查结果,观察并分析尿液颜色和术后反应。结果:6例患者均成功行肾动脉栓塞术。5例患者术后各项指标及肉眼血尿颜色较术前改善。无严重并发症反应发生。
结论：对于常染色体显性多囊肾综合征伴肉眼血尿患者，经导管动脉栓塞术是安全有效的。
